Alibaba Fined in Landmark Antitrust Case

Alibaba Fined in Landmark Antitrust Case

Assessment

Interactive Video

Business, Social Studies

University

Hard

Created by

Quizizz Content

FREE Resource

Alibaba is working to reset its relationship with regulators after receiving a $2.8 billion fine for antitrust violations. The company avoided more severe penalties like a breakup or divestment of key assets. The investigation into Alibaba's monopolistic practices concluded quickly, and the company is expected to change its business practices to improve competition. However, uncertainty remains around the future of its fintech arm, Ant Group, and its media holdings. The regulatory environment is becoming more stringent, affecting other companies like Tencent, as the government scrutinizes expansion and competitive practices.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was the outcome of the antitrust investigation into Alibaba?

Alibaba had to divest key assets.

Alibaba was ordered to break up.

Alibaba was fined $2.8 billion.

Alibaba's CEO was replaced.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a major unresolved issue concerning Alibaba's fintech arm, Ant Group?

Whether it will be allowed to launch an IPO.

How it will be reshaped under regulatory oversight.

Whether it will expand into Europe.

If it will merge with Tencent.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What aspect of Alibaba's business is under scrutiny for having too much influence?

Its media holdings.

Its logistics operations.

Its cloud computing services.

Its e-commerce platform.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which other company is mentioned as potentially facing new regulatory scrutiny?

Baidu

JD.com

Huawei

Tencent

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How does the duration of Alibaba's antitrust investigation compare to similar investigations in the West?

It was much shorter.

It was about the same length.

It was much longer.

It was inconclusive.